NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the publication of a new multi-domain model for capturing functional ...
A phase I/II trial of NOX66 in combination with nivolumab in patients (pts) with advanced cancer. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a ...
Older individuals generally place high value on 'aging in place' – maintaining independence and remaining in their own home. [1] If maintaining this function is the focus of care for the older patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback